• Home
  • >
  • CorDx
  • >
  • CorDx TyFast : Flu A/B & COVID-19 Test (At-Home Multiplex Rapid Test)

CorDx TyFast : Flu A/B & COVID-19 Test (At-Home Multiplex Rapid Test)

Regular price $20.95
Sale price $20.95 Regular price $20.95
Unit price
Save 0%
In Stock
Choose your purchase type:

Subscription Details:

  • Save 10% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.

  • Same-day shipping on all orders. Free over $250.

  • Save 10% on auto-renew orders.  Learn more
  • Interested in our wholesale program?  Join now
Stay Ahead, Stay Safe! Order Your CorDx Tyfast Multiplex Test Today!
First of it's kind for the upcoming 2024-2025 respiratory season.

Leverage the power of CorDx's innovation with CorDx Tyfast Flu A/B & COVID-19 At Home Multiplex Rapid Test. This leading-edge lateral flow assay brings rapid, accurate, and simultaneous qualitative detection of influenza A, influenza B, and SARS-CoV-2 antigens right to the at-home in 10 mins. Designed for convenience and accuracy, this test is a game-changer for individuals showing symptoms of respiratory infection.
  • Each Box Contains: 1 Test cassette, 1 Swab, 1 Tube with sample processing solution, 1 Quick reference instructions
  • Swift Clarity: Receive results rapidly in 10 minutes for early decision-making.
  • Trusted Precision: Clinically validated, providing confidence in every test, simultaneously identifies influenza A, influenza B, and SARS-CoV-2 antigens.
  • User-Friendly: Easy to use design, effortless self-administration, whether at home or on the go.
  • EXPIRATION: Jan 2025 + 1 year additional extension via FDA
For diagnostic use.
For ages 2 years and older.
For Emergency Use Authorization (EUA) only.
Do not use if you've had symptoms longer than 5 days or no symptoms at all.
Store sealed at 36-86°F/2-30°C.
This test does NOT determine if you had COVID-19 in the past or if you have immunity.
Persons with risk factors for severe disease from respiratory pathogens should consult and follow-up with a healthcare provider.
For information about current expiration dates for at-home OTC COVID-19/influenza diagnostic tests, please visit: http://www.fda.gov/covid-tests.

In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization.
This product has been authorized only for the detection of proteins from SARS-CoV-2, Influenza A, and Influenza B, not for any other viruses or pathogens.
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Determining a negative result requires multiple tests. You may need to purchase additional tests to perform serial (repeat) testing. This test is more likely to give you a false negative result when you have COVID-19 than a lab-based molecular test.

Product Documentation:

Quick Reference Instructions
Instruction-for-use
Healthcare Provider Fact Sheet
Interpreting Results